Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine Feliciano

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Cancer Journal (Sudbury, Mass.)|May 28, 2013
Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancerJosephine Feliciano, Steven Feigenberg, Minesh Mehta
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 22, 2018
Lung cancer and family-centered patient concernsJosephine Feliciano, Breanna Becker, Manish Shukla, et al.
Annals of Translational Medicine|October 24, 2017
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancerKhinh Ranh Voong, Josephine Feliciano, Daniel Becker, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims dataJosephine Feliciano, Lisa Gardner, Franklin Hendrick, et al.
Annals of the American Thoracic Society|March 12, 2015
Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary diseaseJanaki A Deepak, Xinyi Ng, Josephine Feliciano, et al.
Current Medical Research and Opinion|September 21, 2021
Study of patient characteristics, treatment patterns, <i>EGFR</i> testing patterns and outcomes in real-world patients with <i>EGFR</i>m<sup>+</sup> non-small cell lung cancerKatherine B Winfree, Kristin M Sheffield, Zhanglin Lin Cui, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2016
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumorsMartin J Edelman, Rena Lapidus, Josephine Feliciano, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2018
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinomaVinod Varki, Olga B Ioffe, Soren M Bentzen, et al.
Human Pathology|July 19, 2014
GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinomaMartin J Edelman, Josephine Feliciano, Binbin Yue, et al.
Future Oncology (London, England)|December 5, 2025
Real-world treatment patterns and attrition for non-driver mutation metastatic non-small cell lung cancer in the USAdam J Schoenfeld, Chen Hu, Ravi Rajaram, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Cancer Journal (Sudbury, Mass.)|May 28, 2013
Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancerJosephine Feliciano, Steven Feigenberg, Minesh Mehta
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 22, 2018
Lung cancer and family-centered patient concernsJosephine Feliciano, Breanna Becker, Manish Shukla, et al.
Annals of Translational Medicine|October 24, 2017
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancerKhinh Ranh Voong, Josephine Feliciano, Daniel Becker, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims dataJosephine Feliciano, Lisa Gardner, Franklin Hendrick, et al.
Annals of the American Thoracic Society|March 12, 2015
Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary diseaseJanaki A Deepak, Xinyi Ng, Josephine Feliciano, et al.
Current Medical Research and Opinion|September 21, 2021
Study of patient characteristics, treatment patterns, <i>EGFR</i> testing patterns and outcomes in real-world patients with <i>EGFR</i>m<sup>+</sup> non-small cell lung cancerKatherine B Winfree, Kristin M Sheffield, Zhanglin Lin Cui, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2016
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumorsMartin J Edelman, Rena Lapidus, Josephine Feliciano, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2018
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinomaVinod Varki, Olga B Ioffe, Soren M Bentzen, et al.
Human Pathology|July 19, 2014
GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinomaMartin J Edelman, Josephine Feliciano, Binbin Yue, et al.
Future Oncology (London, England)|December 5, 2025
Real-world treatment patterns and attrition for non-driver mutation metastatic non-small cell lung cancer in the USAdam J Schoenfeld, Chen Hu, Ravi Rajaram, et al.
Pageof 5